Cargando…
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
IMPORTANCE: Post–COVID-19 condition (PCC), also known as long COVID, affects many individuals. Prevention of PCC is an urgent public health priority. OBJECTIVE: To examine whether treatment with nirmatrelvir in the acute phase of COVID-19 is associated with reduced risk of PCC. DESIGN, SETTING, AND...
Autores principales: | Xie, Yan, Choi, Taeyoung, Al-Aly, Ziyad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037200/ https://www.ncbi.nlm.nih.gov/pubmed/36951829 http://dx.doi.org/10.1001/jamainternmed.2023.0743 |
Ejemplares similares
-
Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
por: Xie, Yan, et al.
Publicado: (2023) -
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records
por: Xie, Yan, et al.
Publicado: (2023) -
Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
por: Fung, Kin Wah, et al.
Publicado: (2023) -
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022) -
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications
por: Dormuth, Colin R., et al.
Publicado: (2023)